Protein folding in neurodegenerative diseases
Pro Research Analysisby 
Searched over 200M research papers
Protein Folding and Misfolding in Neurodegenerative Diseases
Protein folding is a critical process that ensures proteins achieve their correct three-dimensional structure to function properly. In neurodegenerative diseases, this process often goes wrong, leading to protein misfolding and aggregation, which are central features of conditions such as Alzheimer’s, Parkinson’s, Huntington’s, amyotrophic lateral sclerosis (ALS), and prion diseases 1368+2 MORE.
Role of Chaperones and Quality Control Systems in Protein Folding
Cells rely on molecular chaperones and quality control systems, including the ubiquitin-proteasome system and autophagy, to assist in proper protein folding and to eliminate misfolded proteins. When these systems fail or become overwhelmed, misfolded proteins accumulate, forming toxic aggregates that disrupt cellular function and lead to neurodegeneration 1368+1 MORE.
Mechanisms Leading to Protein Misfolding
Protein misfolding can result from genetic mutations, environmental factors, or cellular stress. Mutations in genes encoding proteins such as amyloid precursor protein, alpha-synuclein, and others have been linked to familial forms of neurodegenerative diseases, while sporadic cases may be triggered by environmental toxins or age-related decline in cellular maintenance systems 4710. Additionally, excessive production of reactive oxygen and nitrogen species (ROS/RNS) can modify proteins post-translationally, further promoting misfolding and aggregation 47.
Cellular Stress Responses: ER Stress and the Unfolded Protein Response
Disruption of protein folding homeostasis often leads to endoplasmic reticulum (ER) stress. Cells respond by activating the unfolded protein response (UPR), a signaling pathway aimed at restoring balance by enhancing protein folding capacity and promoting degradation of misfolded proteins. Persistent ER stress, however, can contribute to cell death and disease progression 28.
Consequences of Protein Aggregation in the Brain
The accumulation of misfolded proteins and their aggregates is toxic to neurons. These aggregates can impair synaptic function, disrupt mitochondrial activity, and ultimately lead to neuronal death. The specific symptoms and affected brain regions depend on the type of protein involved and the disease in question 169.
Therapeutic Strategies Targeting Protein Misfolding
Current and emerging therapies focus on enhancing the cell’s ability to manage misfolded proteins. Approaches include boosting chaperone activity, activating the heat shock response, modulating the UPR, and improving degradation pathways like the proteasome and autophagy. Some treatments also aim to reduce oxidative stress or inhibit the formation of toxic protein aggregates 1678. Collaborative research efforts are accelerating the development of these therapies, though challenges remain in identifying effective drug targets and reliable biomarkers for disease monitoring .
Conclusion
Protein misfolding and aggregation are fundamental to the development and progression of many neurodegenerative diseases. Understanding the molecular mechanisms behind protein folding, the failure of quality control systems, and the resulting cellular stress responses is crucial for developing effective treatments. Ongoing research continues to explore new therapeutic strategies to prevent, reverse, or slow the progression of these devastating disorders 1234+5 MORE.
Sources and full results
Most relevant research papers on this topic